Fishawack Health, a UK-based global commercialisation partner for the modern life science era, announced on Tuesday that it has named Jonathan (Jon) Koch as its new chief executive officer.
In the new role, Koch is to lead Fishawack Health through its next stage of growth, which is focused on building and retaining talented teams and delivering a complete set of integrated services for customers across the life science industry.
Koch has spent his complete career in the healthcare sector, including around 12 years at Covance as group president of Clinical Development and Commercialisation services. He has served as senior vice president and CEO of Global Dental at Henry Schein.
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign